additional

NewAmsterdam Pharma Announces Closing of Upsized $479.0 Million Public Offering of Ordinary Shares and Pre-Funded Warrants, Including Full Exercise of the Underwriters Option to Purchase Additional Shares

December 13, 2024 17:16 ET | Source: NewAmsterdam Pharma N.V. NAARDEN, The Netherlands and MIAMI, Dec. 13, 2024 (GLOBE NEWSWIRE)…

7 days ago

NewAmsterdam Pharma Announces Closing of Upsized $479.0 Million Public Offering of Ordinary Shares and Pre-Funded Warrants, Including Full Exercise of the Underwriters Option to Purchase Additional Shares

December 13, 2024 17:16 ET | Source: NewAmsterdam Pharma N.V. NAARDEN, The Netherlands and MIAMI, Dec. 13, 2024 (GLOBE NEWSWIRE)…

1 week ago

NewAmsterdam Pharma Announces Closing of Upsized $479.0 Million Public Offering of Ordinary Shares and Pre-Funded Warrants, Including Full Exercise of the Underwriters Option to Purchase Additional Shares

December 13, 2024 17:16 ET | Source: NewAmsterdam Pharma N.V. NAARDEN, The Netherlands and MIAMI, Dec. 13, 2024 (GLOBE NEWSWIRE)…

1 week ago

NEXTCHEM (MAIRE) AWARDED BY DG FUELS AN EARLY ENGINEERING, LICENSING AND PDP CONTRACT BASED ON ITS PROPRIETARY NX CIRCULAR GASIFICATION TECHNOLOGY FOR AN ADDITIONAL SUSTAINABLE AVIATION FUEL (SAF) PLANT IN NEBRASKA (USA)

Licensing and PDP are subject to Notice to ProceedThis is NEXTCHEM's second SAF initiative with DG Fuels, following the successful…

2 weeks ago

Nova Leap Health Corp. enters into Term Sheet to amend itsCredit Agreement for up to an Additional $7 millionto Support Continued Growth

NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES HALIFAX, Nova Scotia, Nov. 26, 2024…

4 weeks ago

Cytokinetics Presents Additional Data From GALACTIC-HF at the American Heart Association Scientific Sessions 2024

SOUTH SAN FRANCISCO, Calif., Nov. 16, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced new data from post-hoc…

1 month ago

Psyence Biomedical Announces Results from Annual and Special General Meeting, Share Consolidation and Receipt of Additional Staff Determination from Nasdaq

November 12, 2024 16:30 ET | Source: Psyence Biomedical Ltd. NEW YORK, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Psyence Biomedical…

1 month ago